Patents by Inventor Nancy Y. Ip

Nancy Y. Ip has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8580929
    Abstract: The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: November 12, 2013
    Assignee: The Hong Kong University of Science and Technology
    Inventors: Nancy Y. Ip, William M. W. Cheung
  • Publication number: 20130177985
    Abstract: The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2.
    Type: Application
    Filed: August 24, 2012
    Publication date: July 11, 2013
    Applicant: The Hong Kong University of Science and Technology
    Inventors: Nancy Y. Ip, William M.W. Cheung
  • Publication number: 20110087006
    Abstract: The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2.
    Type: Application
    Filed: December 19, 2008
    Publication date: April 14, 2011
    Applicant: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Nancy Y. Ip, William M. W. Cheung
  • Patent number: 7605265
    Abstract: Novel heterodimers of tetrahydroacridines and tetrahydroquinolinones are disclosed. The heterodimers are capable of acting as both acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists. The heterodimers may be used to improve cognitive defects via treatment or prevention in both humans and non-humans.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: October 20, 2009
    Assignee: Biotechnology Research Corporation Ltd.
    Inventors: Nancy Y Ip, Fanny Chui Fun Ip, Yueqing Hu, Yifan Han, Sookja Kim Chung
  • Publication number: 20080176308
    Abstract: Novel heterodimers of tetrahydroacridines and tetrahydroquinolinones are disclosed. The heterodimers are capable of acting as both acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists. The heterodimers may be used to improve cognitive defects via treatment or prevention in both humans and non-humans.
    Type: Application
    Filed: January 22, 2007
    Publication date: July 24, 2008
    Applicant: BIOTECHNOLOGY RESEARCH CORPORATION LIMITED
    Inventors: Nancy Y. IP, Fanny Chui Fun IP, Yueqing Hu, Yifan Han, Sookja Kim Chung
  • Patent number: 7276595
    Abstract: The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: October 2, 2007
    Assignee: Hong Kong University of Science & Technology Inc.
    Inventors: Nancy Y. Ip, William M. W. Cheung
  • Publication number: 20030162268
    Abstract: The present invention concerns a novel retinoic acid (RA) regulated gene whose expression product displays useful morphogenic/mitogenic properties.
    Type: Application
    Filed: April 8, 2003
    Publication date: August 28, 2003
    Inventors: Nancy Y. Ip, William M. W. Cheung
  • Patent number: 6569625
    Abstract: According to the present invention there is provided a method for determining the phylogeny of sample Fritillaria genetic material.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: May 27, 2003
    Assignee: The Hong Kong University of Science & Technology
    Inventors: Karl W. K. Tsim, Nancy Y. Ip, Nikolaus J. Sucher
  • Publication number: 20030017590
    Abstract: The invention provides a method for rapid production of pure CNS neurons from a cancer cell line comprising the steps of:
    Type: Application
    Filed: November 8, 1999
    Publication date: January 23, 2003
    Inventors: NANCY Y. IP, WILLIAM M.W. CHEUNG
  • Publication number: 20020102643
    Abstract: Novel dorsal growth inducing factors, complexes including the factors, and DNA or RNA coding sequences for the factors are described.
    Type: Application
    Filed: July 2, 2001
    Publication date: August 1, 2002
    Inventors: David M. Valenzuela, Nancy Y. Ip, Henryk D. Cudny, George D. Yancopoulos, Richard M. Harland, William C. Smith, Teresa Lamb, Anne Knecht
  • Patent number: 6277593
    Abstract: Novel dorsal growth inducing factors, complexes including the factors, and DNA or RNA coding sequences for the factors are described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: August 21, 2001
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of the Univ. of California
    Inventors: David M. Valenzuela, Nancy Y. Ip, Henryk D. Cudny, George D. Yancopoulos, Richard M. Harland, William C. Smith, Teresa Lamb, Anne Knecht
  • Patent number: 5843775
    Abstract: Novel dorsal growth inducing factors, complexes including the factors, and DNA or RNA coding sequences for the factors are described.
    Type: Grant
    Filed: September 22, 1995
    Date of Patent: December 1, 1998
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of University of California
    Inventors: David M. Valenzuela, Nancy Y. Ip, Henryk D. Cudny, George D. Yancopoulos, Richard M. Harland, William C. Smith, Teresa Lamb, Anne Knecht
  • Patent number: 5360740
    Abstract: An assay system useful for detecting denervated or degenerating muscle by measuring the amount of soluble ciliary neurotrophic factor receptor in body fluids is described.
    Type: Grant
    Filed: July 2, 1992
    Date of Patent: November 1, 1994
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Nancy Y. Ip, Peter S. DiStefano, Neil Stahl
  • Patent number: 5206137
    Abstract: A method for obtaining polynucleotide sequences which are useful for detecting Variable Tandem Repeat polymorphism at multiple genetic loci and other genetic analyses under high stringency conditions (hence, with high specificity) is herein disclosed. Also disclosed are polynucleotide sequences and other compositions useful for DNA polymorphism and other genetic analyses.
    Type: Grant
    Filed: November 21, 1991
    Date of Patent: April 27, 1993
    Assignee: Lifecodes Corporation
    Inventors: Nancy Y. Ip, Howard J. Baum
  • Patent number: 5192658
    Abstract: Polynucleotide sequences and other compositions useful for DNA polymorphism and other genetic analyses are disclosed herein. Also disclosed is a method for obtaining Variable Tandem Repeat polymorphism at a single genetic locus as well as other genetic analyses.
    Type: Grant
    Filed: March 30, 1989
    Date of Patent: March 9, 1993
    Assignee: Lifecodes Corporation
    Inventors: Zvi G. Loewy, Nancy Y. Ip, Howard J. Baum, Susan L. Leary, Ingrid L. M. van de Stadt